Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Access selects BioScrip as exclusive distribution and service partner for MuGard

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has signed an exclusive specialty distribution agreement with BioScrip for its lead product, MuGard -- an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.

20 Jul 2010

ASTRO accepts 4 abstracts on Stereotactic Body Radiation Therapy for NSCLC

The American Society for Radiation Oncology (ASTRO) has accepted four abstracts from users of Elekta Stereotactic Body Radiation Therapy (SBRT) technology on the use of SBRT to treat non-small cell lung cancer (NSCLC). The clinicians will present their findings during presentations at ASTRO's 52nd Annual Meeting (October 31 - November 4) at the San Diego Convention Center.

From Elekta 20 Jul 2010

John Theurer Cancer Center to acquire TrueBeam system for treating cancer patients

In a promising development for cancer patients in New Jersey and surrounding areas, the John Theurer Cancer Center at Hackensack University Medical Center announced today that it will be the first cancer center in New Jersey to acquire an innovative system that enables a radically different approach to treating cancer with image-guided radiotherapy known as the TrueBeam- system.

20 Jul 2010

IBA Dosimetry to showcase Blue Phantom[2] radiation therapy commissioning solution with LDA-99SC at AAPM

IBA Dosimetry, member of IBA Group, will showcase its latest innovation in radiation therapy commissioning solutions, the Blue Phantom[2] water phantom equipped with advanced Linear Diode Array technology (LDA-99SC), at the American Association of Physicists in Medicine Annual Meeting in Philadelphia, July 18 - 22, 2010.

19 Jul 2010

An overview of AAPM annual meeting

AAPM is the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology. Its membership includes medical physicists who specialize in research that develops cutting-edge technologies and board-certified clinical medical physicists who apply these technologies in community hospitals, clinics, and academic medical centers.

16 Jul 2010

Philadelphia to host 52nd annual meeting of American Association of Physicists in Medicine

Next week the city of Philadelphia will host the 52nd annual meeting of the American Association of Physicists in Medicine (AAPM), the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology.

16 Jul 2010

Meningiomas account for about 25% of primary brain tumors: Mayo Clinic Health Letter

Meningiomas, the most common type of brain tumors, are rarely cancerous and may not require treatment. The July issue of Mayo Clinic Health Letter offers an overview of this brain tumor that is usually benign.

16 Jul 2010

ABR qualifies eDataAudit as Practice Quality Improvement for Maintenance of Certification

D3 Radiation Services announced today that the American Board of Radiology (ABR) has qualified eDataAudit--a new service designed to reduce errors in the delivery of radiation therapy--as a Practice Quality Improvement (PQI) for the purpose of Maintenance of Certification (MOC).

15 Jul 2010

Varian adopts Varicent for administering Sales Performance Management needs

Varicent Software Incorporated, the leading innovator in incentive compensation (ICM) and sales performance management (SPM) solutions, announced today that a business unit within Varian Medical Systems, the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions, has selected Varicent for administering its complex sales incentive compensation plans and sales performance management activities.

14 Jul 2010

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

Concord Medical announces joint venture with Chang'An Hospital for operation of cancer treatment facilities

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that effective as of July 1, 2010 it has entered into a joint venture with Chang'An Hospital for the operation of Chang'An Hospital's cancer treatment facilities by acquiring a 52% equity interest in Xi'an Wan Jie Hua Xiang Medical Technology Development Limited.

12 Jul 2010

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

People diagnosed with breast, bowel and ovarian cancers and non-Hodgkin's lymphoma are today twice as likely to survive for at least 10 years as those diagnosed in the early 1970s according to new figures1 released by Cancer Research UK.

12 Jul 2010

Skandion Clinic selects IBA for installation of particle therapy facility

IBA (Ion Beam Applications S.A.) announced that Skandion Clinic, the clinical centre for proton therapy in Sweden, has selected IBA for the installation of a particle therapy facility. This new center will be managed by a consortium of seven Swedish counties, representing eight university hospitals.

9 Jul 2010

ESMO releases revised set of clinical guidelines for cancer patient care

The European Society for Medical Oncology just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.

8 Jul 2010

MonoSol partner Strativa receives FDA approval for Zuplenz OSF

MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, in collaboration with APR Applied Pharma Research s.a. of Switzerland and Labtec GmbH of Germany, today announced that its partner, Strativa Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for Zuplenz® oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting.

8 Jul 2010

Concord Medical files annual report for fiscal 2009 on Form 20-F

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has filed its annual report for the fiscal year ended December 31, 2009 on Form 20-F with the U.S. Securities and Exchange Commission on June 30, 2010.

7 Jul 2010

Rogue stem cells capable of kick-starting melanoma skin cancer development discovered

Researchers at Stanford University School of Medicine in the US have discovered that rogue stem cells appear to be capable of kick-starting the development of melanoma skin cancer in humans.

3 Jul 2010

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software. Using the arc-based Elekta VMAT delivery method, Monaco displays how the radiation dose should be applied — its distribution and strength on the target. The result is a therapy that not only is rapid, but also fine-tuned to treat cancer and avoid healthy tissues.

From Elekta 3 Jul 2010

Strativa receives FDA approval for Zuplenz oral soluble film

Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.

3 Jul 2010

Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has revealed new results from a global survey demonstrating that 66% of patients with metastatic colorectal cancer (mCRC) are now tested for KRAS to determine if they could benefit from a personalized therapy, such as Erbitux® (cetuximab). This represents a 50% increase in levels of KRAS testing in just one year.

1 Jul 2010

Radiotherapy News and Research

Further Reading

Access selects BioScrip as exclusive distribution and service partner for MuGard

ASTRO accepts 4 abstracts on Stereotactic Body Radiation Therapy for NSCLC

John Theurer Cancer Center to acquire TrueBeam system for treating cancer patients

IBA Dosimetry to showcase Blue Phantom[2] radiation therapy commissioning solution with LDA-99SC at AAPM

An overview of AAPM annual meeting

Philadelphia to host 52nd annual meeting of American Association of Physicists in Medicine

Meningiomas account for about 25% of primary brain tumors: Mayo Clinic Health Letter

ABR qualifies eDataAudit as Practice Quality Improvement for Maintenance of Certification

Varian adopts Varicent for administering Sales Performance Management needs

Highlights of AAPM 52nd meeting

Concord Medical announces joint venture with Chang'An Hospital for operation of cancer treatment facilities

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

Skandion Clinic selects IBA for installation of particle therapy facility

ESMO releases revised set of clinical guidelines for cancer patient care

MonoSol partner Strativa receives FDA approval for Zuplenz OSF

Concord Medical files annual report for fiscal 2009 on Form 20-F

Rogue stem cells capable of kick-starting melanoma skin cancer development discovered

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

Strativa receives FDA approval for Zuplenz oral soluble film

Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News